Costimulatory and coinhibitory receptors on T cells are key mediators of the overall immune response, and the clinical success of checkpoint inhibitor therapies has proven the therapeutic benefits of targeting these pathways Viable, cryopreserved dissociated tissue provides an opportunity to understand the dynamic expression patterns of these receptor/lig and sets at the single cell level, providing insights into the differential expression of each receptor/ligand pair across different cancer indications as a means to target new therapeutic interventions.
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con